Dot In

Dot In is a healthcare company in Seoul, South Korea, founded in 2015. It has raised $14.9M across 2 rounds, most recently a $4.6M Series B in 2018 (est.).

Making the world accessible dot by Dot.

Headquarters
Seoul
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$14.9M
Last Round
$4.6M Series BJan 2018
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Dot Inc. is a global leader in inclusive technology for the blind, low-vision, and mobility-impaired, pioneering the world's first tactile display for visually impaired users. The company's core products include the Dot Pad (a revolutionary tactile graphics and multiline Braille display integrated with Apple's accessibility framework), the Dot Kiosk (the world's first barrier-free self-service kiosk with automatic height adjustment), and the Dot Cell (compact, cost-efficient Braille cells for scalable assistive devices). As a certified B Corporation and award-winning social venture with over 290 patents, Dot Inc. collaborates with governments, NGOs, and tech companies to embed inclusive technology into public infrastructure worldwide.

Summary

It lists 11–50 employees. It has raised $14.9M in total across 2 rounds, most recently a $4.6M Series B round in 2018 (est.).

Funding History

Data from Indexed.vcUpdated
Series BSeries B2018 (est.)
$4.6M

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dot In on Indexed.vc
<a href="https://indexed.vc/companies/dot-in"><img src="https://indexed.vc/api/badge/company/dot-in" alt="Dot In on Indexed.vc" width="260" height="76" /></a>